Blood Cells, Molecules, and Diseases (BCMD) publishes original articles and reviews in the broad area
of hematology, including both basic and clinical studies and encompassing areas such as hemostasis, thrombosis, immunology, metabolism,
genetics, molecular biology, therapy, and morphology. Letters to the Editor are also welcome. Contributing Editors are encouraged to
write or solicit a commentary on an article accepted for publication.
Manuscript Checklist
Size
Size limits
are flexible within the approximate range of 1000 to 10,000 words. With figures, tables, and references appropriate to the subject matter,
articles will, in general, not be longer than 20 journal pages. Letters to the Editor and Commentaries are limited to fewer than 1000
words.
Format
Please provide the following on the title page of original articles and reviews: •Title (concise
and informative) •Author names and affiliation addresses (where the work was done) •Corresponding author. Designate
one author who will handle all correspondence at all stages of the process.
Followed by (in this order): •The names and
addresses of three potential referees. •Abstract •Keywords (maximum of 5) •Introduction •Materials
•Results •Discussion •Acknowledgments •References •Tables •Figure captions •Figures,
schemes, illustrations (as separate files)
Letters to the Editor:
Letters must be limited to fewer than 1000 words,
not inclusive of figures and tables. References must not number more than 8. There should be no separate title page, no abstract, no
headings throughout the text, and no materials and methods section. They should be written in the style of a letter with the title at
the top of the page and 'To the Editor' beneath. All authors' names and affiliations should be at the end of the manuscript (including
Corresponding author's full address, email, telephone, and fax numbers). Acceptance is determined by the Contributing Editor.
Commentaries:
Contributing Editors are encouraged to write or solicit a commentary on an article accepted for publication. Commentaries must be limited
to fewer than 1000 words, not inclusive of figures and tables. References must not number more than 8.
For more detailed information
about each of these manuscript components, please see related sections below.
Manuscript Submission
Manuscripts must
be submitted through one of the contributing editors. Authors should contact one of the contributing editors to ascertain whether the
editor is in a position to consider the paper. It is useful to do this by e-mail or fax, including the summary of the paper so that the
editor is apprised of the subject matter of the paper. Please access this link for contributing editor contact information: http://www.elsevier.com/wps/find/journaleditorialboard.cws_home/622796/editorialboard#editorialboard
Because all papers are transmitted electronically (as well as set into print), all manuscripts
must be submitted in electronic form, preferably MS Word for the text. Figures should also be sent in electronic format in a high-resolution
format. They may be sent to the corresponding editor on disk by mail and it is helpful to include a hardcopy of the manuscript and figures.
Submitted articles receive only a light edit so that we will be able to implement immediate distribution. If the references or other
parts of the paper are not in the correct format (see above) or if the paper is not written in good English, it will be returned to the
author for correction.
Color illustrations are encouraged and will be included without additional charge in the electronic edition
of the journal, but will be published as black-and-white versions in the printed journal unless the author pays for the cost of color
reproduction. If the author wishes the printed edition to contain black-and-white versions of colored illustrations, the black-and-white
versions must be supplied along with the color.
Should authors be asked by the Editor to revise their manuscripts, the revision will
be due within 12 weeks. After this time, the manuscript will be considered a new submission.
Further considerations
Upon
acceptance of an article, authors will be asked to transfer copyright (for more information on copyright, see http://authors.elsevier.com).
This transfer will ensure the widest possible dissemination of information. A letter will be sent to the corresponding author confirming
receipt of the manuscript. A form facilitating transfer of copyright will be provided after acceptance.
If material from other copyrighted
works is included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier
has preprinted forms for use by authors in these cases: contact Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK, phone:
(+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions@elsevier.com.
General Information
Submission of an article
implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture
or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and
tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published
elsewhere in the same form, in English or in any other language, without the written consent of the Publisher.
US National Institutes
of Health (NIH) voluntary posting (" Public Access") policy Elsevier facilitates author posting in connection with the voluntary
posting request of the NIH (referred to as the NIH "Public Access Policy"; see http://www.nih.gov/about/publicaccess/index.htm)
by posting the peer-reviewed author's manuscript directly to PubMed Central on request from the author, after formal publication. Upon
notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com)
that your work has received NIH funding (with the NIH award number, as well as the name and e-mail address of the Prime Investigator)
and that you intend to respond to the NIH request. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version
of your manuscript that will include peer-review comments, for posting 12 months after the formal publication date. This will ensure
that you will have responded fully to the NIH request policy. There will be no need for you to post your manuscript directly to PubMed
Central, and any such posting is prohibited.
Authors' rights As an author you (or your employer or institution) may
do the following: - make copies (print or electronic) of the article for your own personal use, including for your own classroom
teaching use - make copies and distribute such copies (including through e-mail) of the article to research colleagues, for the personal
use by such colleagues (but not commercially or systematically, e.g., via an e-mail list or list server) - post a pre-print version
of the article on Internet websites including electronic pre-print servers, and retain indefinitely such version on such servers or sites
- post a revised personal version of the final text of the article (to reflect changes made in the peer review and editing process)
on your personal or institutional website or server, with a link to the journal homepage (on http://www.elsevier.com) -
present the article at a meeting or conference and distribute copies of the article to the delegates attending such a meeting - for
your employer, if the article is a 'work for hire', made within the scope of your employment, your employer may use all or part of the
information in the article for other intra-company use (e.g., training) - retain patent and trademark rights and rights to any processes
or procedure described in the article - include the article in full or in part in a thesis or dissertation (provided that this is
not to be published commercially) - use the article or any part thereof in a printed compilation of your works, such as collected
writings or lecture notes (subsequent to publication of your article in the journal) - prepare other derivative works, extend the
article into book-length form, or otherwise re-use portions or excerpts in other works, with full acknowledgment of its original publication
in the journal
Nomenclature
and units Follow internationally accepted rules and conventions: use the international system of units (SI). If other quantities
are mentioned, give their equivalent in SI. For further information you are urged to consult :
References Please ensure that every
reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given
in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text.
If these references are included in the reference list, they should follow the standard reference style of the journal and should include
a substitution of the publication date with either "Unpublished results" or "Personal communication." Citation of a reference as "in
press" implies that the item has been accepted for publication.
Text References should be numbered (numbers in square brackets)
sequentially as they appear in the text. The actual authors can be referred to, but the reference number(s) must always be given. Example:
"..... as demonstrated [3,6]. Barnaby and Jones [8] obtained a different result ...." Reference List: List all authors when there
are four or fewer, when there are five or more, list the first three, then "et al." Examples: Reference to a journal publication:
[1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton, et al. The art of writing a scientific article, J. Sci. Commun. 163 (2000) 51-59.
Reference to a book: [2] W. Strunk Jr., E.B. White, The Elements of Style, third ed., Macmillan, New York, 1979. Reference
to a chapter in an edited book: [3] G.R. Mettam, L.B. Adams, How to prepare an electronic version of your article, in: B.S. Jones,
R.Z. Smith (Eds.), Introduction to the Electronic Age, E-Publishing Inc., New York, 1999, pp. 281-304.
Citing and listing of
Web references As a minimum, the full URL should be given. Any further information, if known (author names, dates, reference
to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under
a different heading if desired, or can be included in the reference list.
Use of the Digital Object Identifier The digital
object identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alphanumeric character string
which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore,
it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic
information.
The correct format for citing a DOI is: doi:10.1016/j.bcmd.2003.10.071 When you use the DOI to create URL hyperlinks
to documents on the web, they are guaranteed never to change.
Captions
Ensure that each illustration has a caption. Supply
captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description
of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Preparation
of electronic illustrations
General points • Please use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics" or enclose the font. • Only use the following fonts in your illustrations:
Arial, Courier, Helvetica, Times, Symbol. • Number the illustrations according to their sequence in the text. • Use
a logical naming convention for your artwork files. • Provide all illustrations as separate files and as hardcopy printouts
on separate sheets. • Provide captions to illustrations separately. • Produce images near to the desired size of the
printed version.
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If,
together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures
will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced
in color in the printed version. For color reproduction in print, you will receive information regarding the costs from Elsevier after
receipt of your accepted article. Please indicate your preference for color in print or on the Web only. For further information on the
preparation of electronic artwork, please see http://authors.elsevier.com/artwork. Please note: Because of technical
complications which can arise by converting color figures to "gray scale" (for the printed version should you not opt for color in print),
please submit in addition usable black and white versions of all the color illustrations.
Preparation of supplementary data
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the Author
additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets,
sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier
Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is
directly usable, please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic
format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit
our artwork instruction pages at http://authors.elsevier.com.
Proofs
One set of page proofs in PDF format will
be sent by e-mail to the corresponding author, to be checked for typesetting/editing. No changes or additions to the manuscript will
be allowed at this stage. Proofreading is solely the author's responsibility.
